Venetoclax-based regimens in octogenarian patients with CLL: efficacy, safety, and comparison to BTKi in a multicenter cohort

Venetoclax-based regimens in octogenarian patients with CLL: efficacy, safety, and comparison to BTKi in a multicenter cohort

Abstract: Octogenarians represent a significant fraction of patients with chronic lymphocytic leukemia (CLL) but, despite the prevalence of the disease in this age group, limited data are available on the safety and efficacy of novel drugs in this subgroup. We conducted a multicenter retrospective s...

Full description

Saved in:
Bibliographic Details
Main Authors: Andrea Serafin, Alessandro Cellini, Enrica Antonia Martino, Federica Mazzetto, Francesco Angotzi, Anna Maria Frustaci, Monia Marchetti, Riccardo Moia, Alessandro Sanna, Costantino Riemma, Francesca Cibien, Alessandro Noto, Enrico Lista, Myriam Foglietta, Candida Vitale, Vanessa Innao, Martina Bullo, Ester Lovato, Isacco Ferrarini, Costanza Andriola, Laura Ballotta, Idanna Innocenti, Alberto Fresa, Gianmarco Favrin, Marzia Varettoni, Elisa Santambrogio, Lorella Orsucci, Raffaella Pasquale, Massimo Moratti, Luca Laurenti, Marta Coscia, Paolo Sportoletti, Roberto Marasca, Francesca Romana Mauro, Caterina Patti, Enrico Derenzini, Lydia Scarfò, Paolo Ghia, Antonio Cuneo, Alessandra Tedeschi, Livio Trentin, Massimo Gentile, Andrea Visentin
Format: Article
Language:English
Published: Elsevier 2025-07-01
Series:Blood Advances
Online Access:http://www.sciencedirect.com/science/article/pii/S2473952925002277
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items